Yonsei University: Myocardial Ischemia trials

The registry lists 27 Myocardial Ischemia studies with Yonsei University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 4 6No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart DiseaseRecruitingNCT07367893
• Tailored Anti-platelet Therapy After DES Implantation in High-risk PatientsRecruitingNCT05936606Not applicable
• Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow ReserveRecruitingNCT05682118Not applicable
• Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE TrialRecruitingNCT05320926Not applicable
• Gangwon PCI Prospective RegistryRecruitingNCT02038127
• Association of PeRiODontal Disease and gUt Microbiome With Coronary artEry Disease (PRODUCE Study)CompletedNCT05560087
• Diastolic Hyperemia-Free Ratio in Patients With CADCompletedNCT05421169
• CONNECT DES RegistrtyStatus unknownNCT04715594
• Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up StudyStatus unknownNCT03866486
• Optical CoherenCe Tomography-gUided Coronary Intervention in Patients With Complex lesIons: a Randomized Controlled Trial (OCCUPI Trial)CompletedNCT03625908Not applicable
• Assessment of Change in Atherosclerotic Plaque by Serial CCTAStatus unknownNCT03414840
• Clinical Significance of Pre-interventional Optical Coherence Tomography in Bioresorbable Vascular Scaffold ImplantationTerminatedNCT02894697Not applicable
• Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)Active, not recruitingNCT02803411
• A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary LesionsStatus unknownNCT02796157Not applicable
• Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery DiseaseTerminatedNCT02606552Phase 4
• Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery DiseaseStatus unknownNCT02579499Phase 4
• Current Treatment Strategy of Patients With Multivessel Disease or Left Main Coronary Artery Disease Indicated for Coronary Artery Bypass Graft SurgeryStatus unknownNCT02410993
• Yonsei OCT (Optical Coherence Tomography) Registry for Evaluation of Efficacy and Safety of Coronary StentingStatus unknownNCT02099162
• Usefulness of Coronary Computed Tomography Angiography for Therapeutic Decision- Making; RevascularizationStatus unknownNCT02099019
• Korea Transradial Coronary Intervention Prospective Registry (KOTRI)CompletedNCT01803841Phase 4
• DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)CompletedNCT01752894Not applicable
• The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery DiseaseStatus unknownNCT01508663Phase 4
• BES, EES, and ZES-R in Real World PracticeTerminatedNCT01397175Not applicable
• Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent ImplantationCompletedNCT01192724Phase 4
• Prevalence of Coronary Artery Disease in the Siblings of Premature Coronary Heart DiseaseStatus unknownNCT00918242
• Endothelial Dysfunction in Subjects With History of Premature Coronary Artery DiseaseStatus unknownNCT00917527Phase 4
• Evaluation of Zotarolimus Eluting Stent at 3 Months Using Optical Coherence TomographyCompletedNCT00815139